Profile: Verax Biomedical Inc.develops rapid tests. These tests help in the detection of bacterial contaminants in blood components, tissues for transplantation and cellular therapies. Our tests are based upon proprietary Pan Generar Detection(PGDr) technology which permits the rapid detection of a broad array of bacteria in a simple, easy to use test format. Our products include the platelet PGD test procedure which involves pre-treating a freshly collected 500uL platelet sample cell, red cell pgd test and others. Activated leukocytes and other cellular therapies are another area for applicability of PGD technology
FDA Registration Number: 3005935106
5 Products/Services (Click for related suppliers)
|
• Bacterial Detection System For Platelet Transfusion Products (FDA Code: MZC / 866.2560) |
• Cell Therapy Pan Genera Detection (pgd) Tests |
• Multi Analyte Control (FDA Code: JJY / 862.1660) A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls. |
• Platelet Pan Genera Detection (pgd) Tests |
• Red Cell Pan Genera Detection (pgd) Tests |